CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...